Literature DB >> 1653272

Detection of replicative intermediates of hepatitis C viral RNA in liver and serum of patients with chronic hepatitis C.

T L Fong1, M Shindo, S M Feinstone, J H Hoofnagle, A M Di Bisceglie.   

Abstract

The hepatitis C virus is a positive stranded hepatotropic RNA virus. We describe a method of detecting positive and negative strands of hepatitis C viral RNA using the polymerase chain reaction. We tested serum and liver tissue from nine patients with chronic hepatitis C. The positive RNA strand of HCV was detected in the sera and livers of all nine, the negative strand was detected in the livers of eight (89%), and in the sera of five (55%). Titers of both strands of HCV RNA were determined by serial endpoint dilutions. The amount of the negative strand in the serum and liver was usually 10-100 times less than the positive strand. Predigestion of serum with ribonucleases did not alter the detection of the negative strand. This suggests that the negative strand found in the serum may be protected from digestion by being associated with virions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1653272      PMCID: PMC295523          DOI: 10.1172/JCI115368

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Detection of serum hepatitis C virus RNA.

Authors:  S Kaneko; M Unoura; K Kobayashi; K Kuno; S Murakami; N Hattori
Journal:  Lancet       Date:  1990-04-21       Impact factor: 79.321

Review 2.  Flavivirus genome organization, expression, and replication.

Authors:  T J Chambers; C S Hahn; R Galler; C M Rice
Journal:  Annu Rev Microbiol       Date:  1990       Impact factor: 15.500

3.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

4.  Avoiding false positives with PCR.

Authors:  S Kwok; R Higuchi
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

5.  Identification and characterization of type 2 dengue virus replicative intermediate and replicative form RNAs.

Authors:  G R Cleaves; T E Ryan; R W Schlesinger
Journal:  Virology       Date:  1981-05       Impact factor: 3.616

6.  Detection, semiquantitation, and genetic variation in hepatitis C virus sequences amplified from the plasma of blood donors with elevated alanine aminotransferase.

Authors:  P P Ulrich; J M Romeo; P K Lane; I Kelly; L J Daniel; G N Vyas
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

7.  The 5'-terminal sequence of the hepatitis C virus genome.

Authors:  H Okamoto; S Okada; Y Sugiyama; S Yotsumoto; T Tanaka; H Yoshizawa; F Tsuda; Y Miyakawa; M Mayumi
Journal:  Jpn J Exp Med       Date:  1990-06

8.  Detection of hepatitis C virus ribonucleic acid in the serum by amplification with polymerase chain reaction.

Authors:  N Kato; O Yokosuka; M Omata; K Hosoda; M Ohto
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

9.  Detection of hepatitis C viral sequences in blood donations by "nested" polymerase chain reaction and prediction of infectivity.

Authors:  J A Garson; R S Tedder; M Briggs; P Tuke; J A Glazebrook; A Trute; D Parker; J A Barbara; M Contreras; S Aloysius
Journal:  Lancet       Date:  1990-06-16       Impact factor: 79.321

10.  Hepatitis C quantification and sequencing in blood products, haemophiliacs, and drug users.

Authors:  P Simmonds; L Q Zhang; H G Watson; S Rebus; E D Ferguson; P Balfe; G H Leadbetter; P L Yap; J F Peutherer; C A Ludlam
Journal:  Lancet       Date:  1990-12-15       Impact factor: 79.321

View more
  44 in total

1.  Liver iron excess in patients with hepatocellular carcinoma developed on viral C cirrhosis.

Authors:  C Chapoutot; M Esslimani; Z Joomaye; J Ramos; P Perney; C Laurent; P Fabbro-Peray; D Larrey; J Domergue; F Blanc
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

2.  Existence of distinct GB virus C/hepatitis G virus variants with different tropism.

Authors:  M Fogeda; J M López-Alcorocho; J Bartolomé; C Arocena; M A Martín; V Carreño
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor.

Authors:  S Wünschmann; J D Medh; D Klinzmann; W N Schmidt; J T Stapleton
Journal:  J Virol       Date:  2000-11       Impact factor: 5.103

4.  Transfection of HepG2 cells with infectious hepatitis C virus genome.

Authors:  S Dash; A B Halim; H Tsuji; N Hiramatsu; M A Gerber
Journal:  Am J Pathol       Date:  1997-08       Impact factor: 4.307

Review 5.  Immunodiagnosis of viral hepatitides A to E and non-A to -E.

Authors:  G Yang; G N Vyas
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

Review 6.  Hepatitis C virus: molecular biology and genetic variability.

Authors:  C Bréchot
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

7.  Quantification of hepatitis C virus (HCV) in liver specimens and sera from patients with human immunodeficiency virus coinfection by using the Versant HCV RNA 3.0 (branched DNA-based) DNA assay.

Authors:  Rosamaria Tedeschi; Eliana Pivetta; Stefania Zanussi; Ettore Bidoli; Mirna Ros; Giampiero di Gennaro; Guglielmo Nasti; Paolo De Paoli
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

8.  Investigating a new generation of ribozymes in order to target HCV.

Authors:  Michel V Lévesque; Dominique Lévesque; Francis P Brière; Jean-Pierre Perreault
Journal:  PLoS One       Date:  2010-03-10       Impact factor: 3.240

9.  Quantitative detection of hepatitis C virus genome in liver tissue and circulation by competitive reverse transcription-polymerase chain reaction.

Authors:  H Nakagawa; H Shimomura; T Hasui; H Tsuji; T Tsuji
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

10.  Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma.

Authors:  M A Gerber; Y S Shieh; K S Shim; S N Thung; A J Demetris; M Schwartz; G Akyol; S Dash
Journal:  Am J Pathol       Date:  1992-12       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.